Literature DB >> 28964917

Redox imbalance due to the loss of mitochondrial NAD(P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice.

Claudia D C Navarro1, Tiago R Figueira1, Annelise Francisco1, Genoefa A Dal'Bó1, Juliana A Ronchi1, Juliana C Rovani2, Cecilia A F Escanhoela3, Helena C F Oliveira2, Roger F Castilho4, Anibal E Vercesi5.   

Abstract

The mechanisms by which a high fat diet (HFD) promotes non-alcoholic fatty liver disease (NAFLD) appear to involve liver mitochondrial dysfunctions and redox imbalance. We hypothesized that a HFD would increase mitochondrial reliance on NAD(P)-transhydrogenase (NNT) as the source of NADPH for antioxidant systems that counteract NAFLD development. Therefore, we studied HFD-induced liver mitochondrial dysfunctions and NAFLD in C57Unib.B6 congenic mice with (Nnt+/+) or without (Nnt-/-) NNT activity; the spontaneously mutated allele (Nnt-/-) was inherited from the C57BL/6J mouse substrain. After 20 weeks on a HFD, Nnt-/- mice exhibited a higher prevalence of steatohepatitis and content of liver triglycerides compared to Nnt+/+ mice on an identical diet. Under a HFD, the aggravated NAFLD phenotype in the Nnt-/- mice was accompanied by an increased H2O2 release rate from mitochondria, decreased aconitase activity (a redox-sensitive mitochondrial enzyme) and higher susceptibility to Ca2+-induced mitochondrial permeability transition. In addition, HFD led to the phosphorylation (inhibition) of pyruvate dehydrogenase (PDH) and markedly reduced the ability of liver mitochondria to remove peroxide in Nnt-/- mice. Bypass or pharmacological reactivation of PDH by dichloroacetate restored the peroxide removal capability of mitochondria from Nnt-/- mice on a HFD. Noteworthy, compared to mice that were chow-fed, the HFD did not impair peroxide removal nor elicit redox imbalance in mitochondria from Nnt+/+ mice. Therefore, HFD interacted with Nnt mutation to generate PDH inhibition and further suppression of peroxide removal. We conclude that NNT plays a critical role in counteracting mitochondrial redox imbalance, PDH inhibition and advancement of NAFLD in mice fed a HFD. The present study provide seminal experimental evidence that redox imbalance in liver mitochondria potentiates the progression from simple steatosis to steatohepatitis following a HFD.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  C57BL/6J mouse; Liver steatosis; Nnt mutation; Pyruvate dehydrogenase; Steatohepatitis

Mesh:

Substances:

Year:  2017        PMID: 28964917     DOI: 10.1016/j.freeradbiomed.2017.09.026

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  13 in total

1.  Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity.

Authors:  Rebeca Acín-Pérez; Salvador Iborra; Yolanda Martí-Mateos; Emma C L Cook; Ruth Conde-Garrosa; Anton Petcherski; Mª Del Mar Muñoz; Raquel Martínez de Mena; Karthickeyan Chella Krishnan; Concepción Jiménez; Juan Pedro Bolaños; Markku Laakso; Aldon J Lusis; Orian S Shirihai; David Sancho; José Antonio Enríquez
Journal:  Nat Metab       Date:  2020-09-17

Review 2.  Reductive Stress-Induced Mitochondrial Dysfunction and Cardiomyopathy.

Authors:  Wei-Xing Ma; Chun-Yan Li; Ran Tao; Xin-Ping Wang; Liang-Jun Yan
Journal:  Oxid Med Cell Longev       Date:  2020-05-29       Impact factor: 6.543

3.  Resilient hepatic mitochondrial function and lack of iNOS dependence in diet-induced insulin resistance.

Authors:  Pamela A Kakimoto; Bruno Chausse; Camille C Caldeira da Silva; José Donato Júnior; Alicia J Kowaltowski
Journal:  PLoS One       Date:  2019-02-04       Impact factor: 3.240

Review 4.  Strategies to detect mitochondrial oxidants.

Authors:  Alicia J Kowaltowski
Journal:  Redox Biol       Date:  2018-12-05       Impact factor: 11.799

5.  A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models.

Authors:  Eri Kawashita; Keiichi Ishihara; Madoka Nomoto; Mika Taniguchi; Satoshi Akiba
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

Review 6.  Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease.

Authors:  Jelena Stevanović; Jorge Beleza; Pedro Coxito; António Ascensão; José Magalhães
Journal:  Mol Metab       Date:  2019-11-29       Impact factor: 7.422

7.  Antibiotic Disruption of the Gut Microbiota Enhances the Murine Hepatic Dysfunction Associated With a High-Salt Diet.

Authors:  Zheng Zhang; Mengjie Li; Bo Cui; Xiao Chen
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

Review 8.  Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases.

Authors:  David Allan Butterfield; Maria Favia; Iolanda Spera; Annalisa Campanella; Martina Lanza; Alessandra Castegna
Journal:  Molecules       Date:  2022-01-30       Impact factor: 4.411

Review 9.  Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

Authors:  Agostino Di Ciaula; Salvatore Passarella; Harshitha Shanmugam; Marica Noviello; Leonilde Bonfrate; David Q-H Wang; Piero Portincasa
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 10.  Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ignazio Grattagliano; Agostino Di Ciaula; Jacek Baj; Emilio Molina-Molina; Harshitha Shanmugam; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.